Results 121 to 130 of about 10,284,686 (305)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Yeshiva College • 1967 Supplement to catalog 1967/ 69

open access: yes, 1967
Yeshiva Catalog: Supplement to 1967-1969Additional copies of this Supplement are available from the Office of Admissions. See the Catalog for more complete information about programs, regulations, and departments.
Office of the Registrar, Yeshiva College
core  

Supplement use, vitamin C intake and breast cancer risk in UK women [PDF]

open access: yes, 2011
Background: When analysing relationships between breast cancer risk and vitamin C intake, few prospective studies have included vitamin C intake from supplements, or excluded general supplement users in dietary only analyses.
Hutchinson, Jayne
core   +1 more source

Egg consumption and growth in children: a meta-analysis of interventional trials

open access: yesFrontiers in Nutrition
IntroductionStunting and wasting are prevalent in low- and middle-income countries, putting children at risk for disease and disability. Eggs are a nutrient-rich food that can potentially facilitate growth.PurposeThe aim of this meta-analysis was to ...
Elisabeth A. Larson   +3 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

The Commentator : Magazine Supplement ; Monday, May 26, 1969

open access: yes, 1969
Magazine Supplement. Official undergraduate newspaper of Yeshiva College. [Images have been deleted due to copyright restriction.

core  

Editorial Supplement, Biweekly Report for 11 February 1955 [PDF]

open access: yes, 1955
Supplement to the bi-weekly progress report of Division 6 research ...
Bennett, John B.
core  

Desenvolvimento ponderal de bezerras desmamadas em pastejo de Brachiaria decumbens com suplementação protéica e energética Ponderal performances of calves grazing Brachiaria decumbens and supplemented with protein and energetic diets

open access: yesPesquisa Agropecuária Brasileira, 2005
Foi avaliado o efeito da suplementação a pasto, com concentrados fornecidos durante o ano (períodos de seca e águas), sobre o desenvolvimento ponderal de bezerras desmamadas.
José Luiz Viana Coutinho Filho   +2 more
doaj  

Home - About - Disclaimer - Privacy